Skip to main content
. 2020 Dec 14;10:21912. doi: 10.1038/s41598-020-78951-6

Figure 1.

Figure 1

Clinical characteristics of SSc patients from the Zurich cohort at time point of sample collection. mRSS modified Rodnan skin score, dcSSc diffuse cutaneous SSc, lcSSc limited cutaneous SSc, ACA anti-Centromere antibodies, AT-1 anti-topoisomerase I antibodies, FVC forced vital capacity, DLco carbon monoxide diffusion capacity. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, #not significant. N = 12 per group.